Oral administration of the contact sensitizer trinitrochlorobenzene: initial sensitization and subsequent appearance of a suppressor population

Our earlier studies have demonstrated that intragastric administration of the hapten trinitrochlorobenzene (TNCB) 2 to 3 weeks prior to attempting sensitization with epidermally applied hapten can abrogate development of systemic contact sensitivity (CS). In this paper, we have examined whether onse...

Full description

Saved in:
Bibliographic Details
Published in:Cellular immunology Vol. 125; no. 2; p. 437
Main Authors: Gautam, S C, Chikkala, N F, Battisto, J R
Format: Journal Article
Language:English
Published: Netherlands 01-02-1990
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Our earlier studies have demonstrated that intragastric administration of the hapten trinitrochlorobenzene (TNCB) 2 to 3 weeks prior to attempting sensitization with epidermally applied hapten can abrogate development of systemic contact sensitivity (CS). In this paper, we have examined whether onset of tolerance following intragastric administration of the hapten is preceded by development of hapten-specific CS. Indeed, CS was found to be present 5 days after feeding TNCB and in most experiments the response decreased significantly by Days 10 to 12. The kinetics of development of CS by the oral and epidermal routes were strikingly similar except that the magnitude of reactivity (up to 5 days) in orally sensitized mice was somewhat less than that of epidermally sensitized mice. With the exception of Peyer's patches (PP), effector cells of CS were recovered from such gut-associated lymphoid tissues as mesenteric lymph nodes (MLN), lamina propria, and lymphocytes that are present in the intraepithelial compartment of the intestinal wall. These cells as well as spleen cells of TNCB-fed mice were able to adoptively transfer CS to naive mice. The capacity of MLN and spleen cells of TNCB-fed mice to confer CS adoptively was abrogated after treating cells with anti-Thy 1.2 and anti-Lyt 1.1 antibodies plus complement thereby identifying them as T lymphocytes. Although CS decreased by 10-12 days after feeding TNCB, the decline was reversed by pretreating mice with cyclophosphamide (CY) 2 days before giving the hapten. Whereas spleen cells from animals fed hapten 5 days earlier transferred CS readily, those from mice fed hapten 12 days earlier did not. However, when 12-day spleen cells were depleted of Lyt 2+ cells their ability to adoptively transfer CS was restored. These observations indicate that feeding TNCB to mice initially produces CS, mediated by Thy 1.2+, Lyt 1.1+ lymphocytes. CS is subsequently down-regulated by activation of Lyt 2+ suppressor cells, precursors of which are sensitive to CY.
AbstractList Our earlier studies have demonstrated that intragastric administration of the hapten trinitrochlorobenzene (TNCB) 2 to 3 weeks prior to attempting sensitization with epidermally applied hapten can abrogate development of systemic contact sensitivity (CS). In this paper, we have examined whether onset of tolerance following intragastric administration of the hapten is preceded by development of hapten-specific CS. Indeed, CS was found to be present 5 days after feeding TNCB and in most experiments the response decreased significantly by Days 10 to 12. The kinetics of development of CS by the oral and epidermal routes were strikingly similar except that the magnitude of reactivity (up to 5 days) in orally sensitized mice was somewhat less than that of epidermally sensitized mice. With the exception of Peyer's patches (PP), effector cells of CS were recovered from such gut-associated lymphoid tissues as mesenteric lymph nodes (MLN), lamina propria, and lymphocytes that are present in the intraepithelial compartment of the intestinal wall. These cells as well as spleen cells of TNCB-fed mice were able to adoptively transfer CS to naive mice. The capacity of MLN and spleen cells of TNCB-fed mice to confer CS adoptively was abrogated after treating cells with anti-Thy 1.2 and anti-Lyt 1.1 antibodies plus complement thereby identifying them as T lymphocytes. Although CS decreased by 10-12 days after feeding TNCB, the decline was reversed by pretreating mice with cyclophosphamide (CY) 2 days before giving the hapten. Whereas spleen cells from animals fed hapten 5 days earlier transferred CS readily, those from mice fed hapten 12 days earlier did not. However, when 12-day spleen cells were depleted of Lyt 2+ cells their ability to adoptively transfer CS was restored. These observations indicate that feeding TNCB to mice initially produces CS, mediated by Thy 1.2+, Lyt 1.1+ lymphocytes. CS is subsequently down-regulated by activation of Lyt 2+ suppressor cells, precursors of which are sensitive to CY.
Author Gautam, S C
Battisto, J R
Chikkala, N F
Author_xml – sequence: 1
  givenname: S C
  surname: Gautam
  fullname: Gautam, S C
  organization: Research Institute of the Cleveland Clinic Foundation, Ohio 44106
– sequence: 2
  givenname: N F
  surname: Chikkala
  fullname: Chikkala, N F
– sequence: 3
  givenname: J R
  surname: Battisto
  fullname: Battisto, J R
BackLink https://www.ncbi.nlm.nih.gov/pubmed/2137034$$D View this record in MEDLINE/PubMed
BookMark eNo9kM1OwzAQhH0oKm3hDUDyEQ4Bx07imBtU_EmVeoFztXHWalBqG9s50JfglWlp4TTSzOy30kzJyDqLhFzk7CZneXXLGKuzWhbqSrFrxZiS2cOITP7tUzKN8YOxPC8UG5Mxz4VkopiQ72WAnkK76WwXU4DUOUudoWmNVDubQCca0cYudVsMNIVdLwWn170LrkG7RYt3dG92O85f84AB29I4NBE_B7SJgvcIAazG_QPYRd4HjNEF6p0f-t-jM3JioI94ftQZeX96fJu_ZIvl8-v8fpFpUcqU5UaVBQhhVC2haapWI8qScxTGQIu1Qc0FtELVomqgkSihllrwtiq5KIzkM3J54Pqh2WC78qHbQPhaHYfhP6IbbBg
CitedBy_id crossref_primary_10_1016_j_clim_2008_08_028
crossref_primary_10_1196_annals_1309_053
crossref_primary_10_1111_1523_1747_ep12358502
crossref_primary_10_1016_S0041_008X_03_00091_7
crossref_primary_10_1016_0008_8749_91_90287_L
crossref_primary_10_1016_0008_8749_91_90251_6
crossref_primary_10_1111_j_1600_065X_1995_tb00066_x
crossref_primary_10_1111_1523_1747_ep12668010
crossref_primary_10_1111_j_0105_2896_2005_00280_x
crossref_primary_10_1016_0168_8278_95_80432_3
crossref_primary_10_1111_j_1749_6632_1996_tb21134_x
crossref_primary_10_1006_cimm_1997_1119
crossref_primary_10_1016_S0171_2985_11_80107_5
crossref_primary_10_1016_S1286_4579_01_01456_3
crossref_primary_10_1111_j_1600_0625_1993_tb00010_x
crossref_primary_10_1111_j_1365_2249_2006_03207_x
crossref_primary_10_1016_S0923_2494_99_80003_0
crossref_primary_10_1002_ana_410290608
crossref_primary_10_1002_eji_1830260814
crossref_primary_10_1046_j_1365_2133_2003_05592_x
crossref_primary_10_1016_S0167_5699_97_01053_0
crossref_primary_10_1084_jem_188_10_1929
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1016/0008-8749(90)90097-B
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
Biology
ExternalDocumentID 2137034
Genre Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: AI-24961
GroupedDBID ---
--K
--M
-~X
.55
.GJ
.~1
0R~
1B1
1KJ
1RT
1~.
1~5
29B
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
6J9
7-5
71M
8P~
9JM
AAAJQ
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AAXKI
AAXUO
ABFRF
ABGSF
ABJNI
ABMAC
ABUDA
ABXDB
ACDAQ
ACGFO
ACGFS
ACNCT
ACRLP
ADBBV
ADEZE
ADFGL
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFJKZ
AFKWA
AFTJW
AFXIZ
AGEKW
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJOXV
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CAG
CGR
CJTIS
COF
CS3
CUY
CVF
DM4
DU5
EBS
ECM
EFBJH
EIF
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HLW
HMG
HVGLF
HX~
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
LG5
LUGTX
LX2
LZ5
M41
MO0
N9A
NPM
O-L
O9-
OAUVE
OHT
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SBG
SDF
SDG
SDP
SES
SEW
SIN
SPCBC
SSI
SSU
SSZ
T5K
UNMZH
WH7
WUQ
X7M
XOL
XPP
Y6R
YYP
ZGI
ZMT
~G-
ID FETCH-LOGICAL-c357t-1f954a33f987abb6dcee7522e3ffade8fec23ad39836bab7e7a87c32d65234f72
ISSN 0008-8749
IngestDate Sat Sep 28 08:34:42 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c357t-1f954a33f987abb6dcee7522e3ffade8fec23ad39836bab7e7a87c32d65234f72
PMID 2137034
ParticipantIDs pubmed_primary_2137034
PublicationCentury 1900
PublicationDate 1990-02-01
PublicationDateYYYYMMDD 1990-02-01
PublicationDate_xml – month: 02
  year: 1990
  text: 1990-02-01
  day: 01
PublicationDecade 1990
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Cellular immunology
PublicationTitleAlternate Cell Immunol
PublicationYear 1990
SSID ssj0011490
Score 1.4757414
Snippet Our earlier studies have demonstrated that intragastric administration of the hapten trinitrochlorobenzene (TNCB) 2 to 3 weeks prior to attempting...
SourceID pubmed
SourceType Index Database
StartPage 437
SubjectTerms Administration, Cutaneous
Administration, Oral
Animals
Antigens, Ly - analysis
Cyclophosphamide - pharmacology
Dermatitis, Contact - etiology
Dermatitis, Contact - immunology
Female
Intestines - immunology
Mice
Mice, Inbred C3H
Phenotype
Picryl Chloride - administration & dosage
Picryl Chloride - immunology
T-Lymphocytes, Regulatory - immunology
Title Oral administration of the contact sensitizer trinitrochlorobenzene: initial sensitization and subsequent appearance of a suppressor population
URI https://www.ncbi.nlm.nih.gov/pubmed/2137034
Volume 125
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1NbxMxELWSoqJeEBQqWj7kA5VA1YrN2rv29gYh0EvLoUXiVtlrW1RNk6jZHNo_wV9mxnbWSQEBBy6rlb3xrjxPk5nxvBlCXpXSWcUcFh_kOuOyqjNpjctEbpoyb1RpOLKRj07FyVf5YcRHvd6y914a-6-ShjGQNTJn_0Ha3aIwAPcgc7iC1OH6V3L_jIx7tVYSd5kHgGnpSImcY9J6e3Frrw9aPMBpsW0W-O1TbSe3oPswSoDDnksSnw0L-Sg7qBqff-0LksP2edKBp1nOFzOfVzu9Pph1jcFWzd-hHY9D3ivSUtYi-p_Uog3gPE2R2-G3i8tLNfYG7klKQsaioFgSwUMwpjyaSOXLl8nOK9pYgjYOJUs7bRx40BF2xYpu5aE6zE86P4QfusX28eh0H_9l81pk71d_Ats3u_JyLwYMVB3_4-SdWtxxpk_6YFih7T087o6swNUMfKf4HUue5qB62429rvM38bu2yGZc7Y5D4w2bs4fkQfRI6LsApUekZyfbZDP0KL3ZJvePY_bFY_IdsUXXsUWnjgK2aMQWTdiiv8TWIY3IomvIooAsmpBFE7LwBYomZNGErCfky8fR2fAoiw09soaVos0Gri65YszVUiitKwMWmgAHwDLnlLGgNpqCKcNqySqttLBCSdGwwlRlwbgTxQ7ZmEwn9imhVhoBvo6zhWacayU1FwXXYN6WttaF2CU7YVPPZ6Fqy3nc7b3fTTwjWwmkz8k9BwrBviD9uVm89JL-AT5shj0
link.rule.ids 782
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oral+administration+of+the+contact+sensitizer+trinitrochlorobenzene%3A+initial+sensitization+and+subsequent+appearance+of+a+suppressor+population&rft.jtitle=Cellular+immunology&rft.au=Gautam%2C+S+C&rft.au=Chikkala%2C+N+F&rft.au=Battisto%2C+J+R&rft.date=1990-02-01&rft.issn=0008-8749&rft.volume=125&rft.issue=2&rft.spage=437&rft_id=info:doi/10.1016%2F0008-8749%2890%2990097-B&rft_id=info%3Apmid%2F2137034&rft_id=info%3Apmid%2F2137034&rft.externalDocID=2137034
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-8749&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-8749&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-8749&client=summon